ArticleFrontiers in medicine2025
Correlations between biological markers of the perirenal adipose tissue and clinical features of patients with localized kidney cancer.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Among the different types of cells that surround renal epithelial cells, human renal adipose tissue (hAT) is one of the most abundant. We have previously characterized the expression of different proteins in hAT (adiponectin, adiponectin receptor 1, leptin, leptin receptor, perilipin 1, and metalloprotease (1). In this study, we evaluated if the differential proteins expression as a whole was sufficient to separate healthy patients from patients with kidney cancer, using unsupervised machine learning algorithms; and the correlation between adiponectin and leptin expression with clinical characteristics of kidney cancer patients. Considering the six biological variables evaluated in the different hAT fragments, we were able to separate healthy from kidney tumor patients by unsupervised machine learning algorithms projection. In addition, a decrease in adiponectin expression was found in patients with a more undifferentiated tumor as well as in patients with a history of smoking. Also, there was a positive correlation between leptin, tumor size and difficulty in tumor dissection. The parameters that increase the difficulty in dissection are male sex, smoking history, tumor size and the fat striation degree in imaging studies. Moreover, PAT (perirenal adipose tissue)-related adipokine signatures reflect systemic metabolic dysfunction, including features of metabolic syndrome, offering additional value for anticipating surgical complexity and refining prognostic stratification. This project represents a new way of looking at kidney cancer, by correlating clinical features with specific biomarkers, we may be able to identify patterns that might predict how the disease will develop. This could lead to more accurate prognoses and more effective treatments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.